MENU
LIXT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lixte Biotechnology Holdings (LIXT) Ownership - Who owns Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors... Show more
Profile
Industry
N/A
Address
680 East Colorado Boulevard
Phone
+1 631 830-7092
Employees
4
Web
https://www.lixte.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.27M
P/E Ratio
N/A
Total Cash
1.64M
Projected Growth
N/A
Total Debt
100K
Revenue
N/A
Risk (Beta)
1.42
Dividend Yield
N/A
Total Cash/Share
0.61
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LIXT
Capitalization
3.28M
P/E Ratio
N/A
Risk (Beta)
1.42
Dividend Yield
N/A
Total Cash
1.64M
Total Cash/Share
0.61
Total Debt
100K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-2.13M
P/B Ratio
12.00
Cash Flow
N/A
Earnings
-1.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
225
Current Ratio
5.13
Current Revenue Per Employee
200000.00
Dividends Per Share - Security
N/A
EBITDA
-3.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-115.45
Shares Held By Institutions
650K
Shares Outstanding - Current
2.68M
Total Liabilities
329K
Total Volume MTD
N/A
Value
-1
Gain YTD
-39.893
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
680 East Colorado Boulevard
Phone
+1 631 830-7092
Employees
4
Web
https://www.lixte.com